Latest Breaking News On - Bio investors - Page 3 : comparemela.com

Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results on March 6, 2023

Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results on March 6, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University of pennsylvaniaUnited statesStuart hendersonMike beyerUniversity of pennsylvania gene therapy programPassage bio incHealthcare communicationsSam brown incPassage bioGene therapy programBio investorsBio media

Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

20.01.2023 - PHILADELPHIA, Jan. 20, 2023 (GLOBE NEWSWIRE) - Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced it has granted .

University of pennsylvaniaUnited statesStuart hendersonMike beyerUniversity of pennsylvania gene therapy programHealthcare communicationsSam brown incInducement optionsGene therapy programBio investorsBio media

Passage Bio Announces Appointment of William Chou, M D as

PHILADELPHIA, Oct. 10, 2022 (GLOBE NEWSWIRE) Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing.

United statesUniversity of pennsylvaniaStuart hendersonMike beyerMaxine gowenWilliam chouYale universityUniversity of pennsylvania gene therapy programUniversity of pittsburgh school medicinePrinceton universityPassage bio incHealthcare communicationsSam brown incExchange commissionYale school of managementAruvant sciences

Passage Bio Announces Appointment of William Chou, M D as Chief Executive Officer

PHILADELPHIA, Oct. 10, 2022 Passage Bio, Inc. , a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced. | October 10, 2022

United statesUniversity of pennsylvaniaStuart hendersonMike beyerMaxine gowenWilliam chouYale universityUniversity of pennsylvania gene therapy programUniversity of pittsburgh school medicinePrinceton universityBio incHealthcare communicationsSam brown incExchange commissionYale school of managementAruvant sciences

Passage Bio to Present at 2022 Wedbush PacGrow Healthcare Virtual Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

University of pennsylvaniaUnited statesSimona kingStuart hendersonMike beyerUniversity of pennsylvania gene therapy programPassage bio incPanel discussionHealthcare communicationsSam brown incPassage bioPacgrow healthcare virtual conferenceGene therapy programBio investorsBio mediaGlobe newswire